Intravaginal practices, vaginal infections and HIV acquisition: Systematic review and meta-analysis

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Hilber, Adriane Martin ^a   Francis, Suzanna C ^b   Chersich, Matthew ^c,d   Scott, Pippa ^a   Redmond, Shelagh ^a   Bender, Nicole ^a   Miotti, Paolo ^e   Temmerman, Marleen ^c   Low, Nicola ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c GHENT UNIVERSITY   (Belgium)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; ARTICLE; CLEANING; CLINICAL TRIAL; EPIDEMIOLOGICAL DATA; EVIDENCE BASED PRACTICE; HAZARD RATIO; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTRAVAGINAL PRACTICE; META ANALYSIS; PROSPECTIVE STUDY; RISK REDUCTION; SEXUAL INTERCOURSE; SYSTEMATIC REVIEW; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; UNITED STATES; VAGINA CANDIDIASIS; VAGINAL LAVAGE; VAGINITIS; AFRICA SOUTH OF THE SAHARA; BIOLOGICAL MODEL; FEMALE; INFECTION; MICROBIOLOGY; REVIEW; VAGINA; VIROLOGY;

BACTERIA (MICROORGANISMS); TRICHOMONAS VAGINALIS;

AFRICA SOUTH OF THE SAHARA; FEMALE; HIV INFECTIONS; HUMANS; INFECTION; MODELS, BIOLOGICAL; UNITED STATES; VAGINA; VAGINAL DOUCHING; VAGINOSIS, BACTERIAL;

EID: 77949351365     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009119     Document Type: Article

References (49)

1. Hilber AM, Chersich MF, van de Wijgert JH, Rees H, Temmerman M (2007) Vaginal practices, microbicides and HIV: what do we need to know? Sex Transm Infect 83: 505-508.
2. Martin Hilber A, Hull TH, Preston-Whyte E, Bagnol B, Wacharasin C, et al. (2010) A Cross Cultural Study of Vaginal Practices and Sexuality: Implications for Sexual Health. Soc Sci Med 70: 392-400.
3. Shattock RJ, Moore JP (2003) Inhibiting sexual transmission of HIV-1 infection. Nature Reviews Microbiology 1: 25-34.
4. Kilmarx PH, Limpakarnjanarat K, Supawitkul S, Korattana S, Young NL, et al. (1998) Mucosal disruption due to use of a widely-distributed commercial vaginal product: potential to facilitate HIV transmission. AIDS 12: 767-773.
5. Mbikusita-Lewanika M, Stephen H, Thomas J (2009) The prevalence of the use of 'dry sex' traditional medicines, among Zambian women, and the profile of the users. Psychol Health Med 14: 227-238.
6. Beksinska ME, Rees HV, Kleinschmidt I, McIntyre J (1999) The practice and prevalence of dry sex among men and women in South Africa: a risk factor for sexually transmitted infections? Sex Transm Infect 75: 178-180.
7. Hira SK, Mangrola UG, Mwale C, Chintu C, Tembo G, et al. (1990) Apparent vertical transmission of human immunodeficiency virus type 1 by breast-feeding in Zambia. J Pediatr 117: 421-424.
8. van de Wijgert JH, Chirenje ZM, Iliff V, Mbizvo MT, Mason PR, et al. (2000) Effect of intravaginal practices on the vaginal and cervical mucosa of Zimbabwean women. J Acquir Immune Defic Syndr 24: 62-67.
9. Francis S (2007) Intravaginal practices in a microbicides feasibility study in Mwanza, Tanzania: baseline associations with Bacterial Vaginosis, sexually transmitted infections and HIV. International Society for STD Research meeting. 29 July-1 August, 2007, Seattle, Washington.
10. Atashili J, Poole C, Ndumbe PM, Adimora AA, Smith JS (2008) Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 22: 1493-1501.
11. McClelland RS, Sangare L, Hassan WM, Lavreys L, Mandaliya K, et al. (2007) Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 195: 698-702.
12. Van Der PB, Kwok C, Pierre-Louis B, Rinaldi A, Salata RA, et al. (2008) Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis 197: 548-554.
13. Myer L, Kuhn L, Stein ZA, Wright TC Jr, Denny L (2005) Intravaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: epidemiological evidence and biological mechanisms. Lancet Infect Dis 5: 786-794.
14. van de Wijgert JH, Morrison CS, Cornelisse PG, Munjoma M, Moncada J, et al. (2008) Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women. J Acquir Immune Defic Syndr 48: 203-210.
15. McClelland RS, Lavreys L, Hassan WM, Mandaliya K, Ndinya-Achola JO, et al. (2006) Vaginal washing and increased risk of HIV-1 acquisition among African women: a 10-year prospective study. AIDS 20: 269-273.
16. Myer L, Denny L, de Souza M, Wright TC Jr, Kuhn L (2006) Distinguishing the temporal association between women's intravaginal practices and risk of human immunodeficiency virus infection: a prospective study of South African women. Am J Epidemiol 163: 552-560.
17. Brown JE, Brown RC (2000) Traditional intravaginal practices and the heterosexual transmission of disease: a review. Sex Transm Dis 27: 183-187.
18. Nugent RP, Krohn MA, Hillier SL (1991) Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29: 297-301.
19. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, et al. (1983) Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 74: 14-22.
20. National Institute for Clinical Excellence (2006) Guideline Development Methods: Information for National Collaborating Centres and Guideline Developers. (February 2004, updated 2005).
21. Knol MJ, Vandenbroucke JP, Scott P, Egger M (2008) What do case-control studies estimate? Survey of methods and assumptions in published case-control research. Am J Epidemiol 168: 1073-1081.
22. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 21: 1539-1558.
23. Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
24. Ghys PD, Diallo MO, Ettiegne-Traore V, Satten GA, Anoma CK, et al. (2001) Effect of interventions to control sexually transmitted disease on the incidence of HIV infection in female sex workers. AIDS 15: 1421-1431.
25. Hawes SE, Hillier SL, Benedetti J, Stevens CE, Koutsky LA, et al. (1996) Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. Journal of Infectious Diseases 174: 1058-1063.
26. Hester RA, Kennedy SB (2003) Candida infection as a risk factor for HIV transmission. J Womens Health 12: 487-494.
27. Hutchinson KB, Kip KE, Ness RB (2007) Vaginal douching and development of bacterial vaginosis among women with normal and abnormal vaginal microflora. Sex Transm Dis 34: 671-675.
28. Kapiga SH, Sam NE, Bang H, Ni Q, Ao TT, et al. (2007) The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania. J Infect Dis 195: 1260-1269.
29. Kleinschmidt I, Rees H, Delany S, Smith D, Dinat N, et al. (2007) Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort. Contraception 75: 461-467.
30. Kumwenda N, Hoffman I, Chirenje M, Kelly C, Coletti A, et al. (2006) HIV incidence among women of reproductive age in Malawi and Zimbabwe. Sex Transm Dis 33: 646-651.
31. Martin HL Jr, Nyange PM, Richardson BA, Lavreys L, Mandaliya K, et al. (1998) Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J Infect Dis 178: 1053-1059.
32. Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, et al. (1999) Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 180: 1863-1868.
33. McClelland RS, Richardson BA, Graham SM, Masese LN, Gitau R, et al. (2008) A prospective study of risk factors for bacterial vaginosis in HIV-1-seronegative African women. Sex Transm Dis 35: 617-623.
34. Myer L, Denny L, Telerant R, Souza M, Wright TC Jr, et al. (2005) Bacterial Vaginosis and Susceptibility to HIV Infection in South African Women: A Nested Case-Control Study. J Infect Dis 192: 1372-1380.
35. Nagot N, Ouedraogo A, Defer MC, Vallo R, Mayaud P, et al. (2007) Association between bacterial vaginosis and Herpes simplex virus type-2 infection: implications for HIV acquisition studies. Sex Transm Infect 83: 365-368.
36. Riedner G, Hoffmann O, Rusizoka M, Mmbando D, Maboko L, et al. (2006) Decline in sexually transmitted infection prevalence and HIV incidence in female barworkers attending prevention and care services in Mbeya Region, Tanzania. AIDS 20: 609-615.
37. Taha TE, Hoover DR, Dallabetta GA, Kumwenda NI, Mtimavalye LA, et al. (1998) Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 12: 1699-1706.
38. van de Wijgert JH, Mason PR, Gwanzura L, Mbizvo MT, Chirenje ZM, et al. (2000) Intravaginal practices, vaginal flora disturbances, and acquisition of sexually transmitted diseases in Zimbabwean women. J Infect Dis 181: 587-594.
39. van de WJ, Morrison C, Salata R, Padian N (2006) Is vaginal washing associated with increased risk of HIV-1 acquisition? AIDS 20: 1347-1348.
40. McClelland RS, Richardson BA, Hassan WM, Chohan V, Lavreys L, et al. (2008) Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial. J Infect Dis 197: 1361-1368.
41. Myer L, Denny L, De SM, Barone MA, Wright TC Jr, et al. (2004) Intravaginal practices, HIV and other sexually transmitted diseases among South African women. Sex Transm Dis 31: 174-179.
42. Grimley DM, Oh MK, Desmond RA, Hook EW III, Vermund SH (2005) An intervention to reduce vaginal douching among adolescent and young adult women: a randomized, controlled trial. Sex Transm Dis 32: 752-758.
43. Rottingen JA, Cameron DW, Garnett GP (2001) A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis 28: 579-597.
44. Kissinger P, Schmidt N, Mohammed H, Leichliter JS, Gift TL, et al. (2006) Patient-delivered partner treatment for Trichomonas vaginalis infection: a randomized controlled trial. Sex Transm Dis 33: 445-450.
45. Karim SA, Coletti A, Richardson B, Ramjee G, Hoffman I, et al. (2009) Safety and effectiveness of vaginal microbicides BufferGel and 0.5% PRO 2000/5 gel for the prevention of HIV infection in women:results of the HPTN035 trial (abstract 48LB). Program and abstracts of the 16th Conference on Retroviruses and Opportunistic Infections Montreal, February 8-11, 2009.
46. van de Wijgert JH, Shattock RJ (2007) Vaginal microbicides: moving ahead after an unexpected setback. AIDS 21: 2369-2376.
47. Van DL, Govinden R, Mirembe FM, Guedou F, Solomon S, et al. (2008) Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. New England Journal of Medicine 359: 463-472.
48. Vincent KL, Bourne N, Bell BA, Vargas G, Tan A, et al. (2009) High resolution imaging of epithelial injury in the sheep cervicovaginal tract: a promising model for testing safety of candidate microbicides. Sex Transm Dis 36: 312-318.
49. Mesquita PM, Cheshenko N, Wilson SS, Mhatre M, Guzman E, et al. (2009) Disruption of Tight Junctions by Cellulose Sulfate Facilitates HIV Infection: Model of Microbicide Safety. J Infect Dis 200: 599-608.